BAFNA PHARMACEUTICALS
Back to Income Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹146 Cr | ₹152 Cr | ₹115 Cr | ₹85 Cr | ₹71 Cr |
What is the latest Revenue of BAFNA PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹146 Cr |
| Mar2025 | ₹152 Cr |
| Mar2024 | ₹115 Cr |
| Mar2023 | ₹85 Cr |
| Mar2022 | ₹71 Cr |
How is Revenue of BAFNA PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹146 Cr | -4.33 | |
| Mar2025 | ₹152 Cr | 32.18 | |
| Mar2024 | ₹115 Cr | 35.48 | |
| Mar2023 | ₹85 Cr | 19.55 | |
| Mar2022 | ₹71 Cr | - | |
Compare Revenue of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹721.7 Cr | 11.8% | 13.7% | 222.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,310.0 Cr | 2% | -1.7% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,426.0 Cr | 6.5% | 14.8% | 48.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,347.0 Cr | 1.2% | -2.5% | 37.2% | Stock Analytics | |
| CIPLA | ₹114,393.0 Cr | -0.3% | -3.9% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,240.2 Cr | -2.2% | 1.5% | -8.3% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 11.8% |
13.7% |
222.1% |
| SENSEX | -0.5% |
-1.3% |
-5.4% |
You may also like the below Video Courses